Back to Profile page

Publication

  1. Sharma AL, Meitei PM, Machathoibi TC, Singh NT, Singh TR, Singh LS, Ovarian cancer G protein-coupled receptor 1 inhibits A549 cells migration through casein kinase 2α intronless gene and neutral endopeptidase. , BMC Cancer, 22(1):143, 2022, JIF: 4.4, Click Here (DOI)
  2. Singh TD, Singh NI, Devi KM, Meiguilungpou R, Khongsai L, Singh LS , Bal NC, Swapana N, Singh CB, Singh TR, Planispine A Sensitized Cancer Cells to Cisplatin by Inhibiting the Fanconi Anemia Pathway, Molecules , Oct 26;27(21):7288., 2022, JIF: 4.9, Click Here (DOI)
  3. Devi MS, Meiguilungpou R, Sharma AL, Anjali C, Devi KM, Singh LS, Singh TR, Spindlin docking protein (SPIN.DOC) interaction with SPIN1 (a histone code reader) regulates Wnt signaling.. , Biochem Biophys Res Commun, 511(3):498-503, 2019, JIF:3.5, Click Here (DOI)
  4. Sharma AL, Singh TR, Singh LS, Antiretroviral resistance, genotypic characterization and origin of Human Immunodeficiency Virus among the infected wives of Intravenous drug users in Manipur, Scientific Reports, 8(1):15183., 2018, JIF:4.3, Click Here (DOI)
  5. Singh SP, Nongalleima K, Singh NI, Doley P, Singh CB, Singh TR, Sahoo D. , Zerumbone reduces proliferation of HCT116 colon cancer cells by inhibition of TNF-alpha, Scientific Reports, 8(1):4090, 2018, JIF:4.3, Click Here (DOI)
  6. Sharma AL, Singh TR, Devi KR, Singh LS, Molecular epidemiology of HIV-1 among the HIV infected people of Manipur, Northeastern India: Emergence of unique recombinant forms, J Med Virol, 89(6):989-999, 2017, JIF:2.3, Click Here (DOI)
  7. Sharma AL, Singh TR, Devi KR and Singh LS. , Prevalence of drug resistance associated mutations among the Retroviral Therapy Exposed HIV-I infected individuals in Manipur, Northeastern India. , Current HIV Research , 14(4):360-70, 2016, JIF: 1.5, Click Here (DOI)
  8. Singh TD, Meitei HT, Sharma AL, Robinson A, Singh LS, Singh TR. , Anticancer properties and enhancement of therapeutic potential of cisplatin by leaf extract of Zanthoxylum armatum DC. , Biological Research., 48:46. , 2015, JIF: 5.6, Click Here (DOI)
  9. Zhao Q, Saro D, Sachpatzidis A, Singh TR, Schlingman D, Zheng XF, Mack A, Tsai MS, Mochrie S, Regan L, Meetei AR, Sung P, Xiong Y, The MHF complex senses branched DNA by binding a pair of crossover DNA duplexes, Nature Communication, 5:2987 , 2014, JIF: 14.9, Click Here (DOI)
  10. Park JY, Singh TR, Nassar N, Zhang F, Freund M, Hanenberg H, Meetei AR, Andreassen PR, Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair, Oncogene, 33, 4803–4812, 2014, JIF: 9.8, Click Here (DOI)
  11. Pradhan A, Singh TR, Ali AM, Wahengbam K, Meetei AR, Monopolar Spindle 1 (MPS1)-dependent Phosphorylation of RecQ mediated genome instability ........, J Biol Chem., 288(47): 33500–33508, 2013, JIF: 5.1, Click Here (DOI)
  12. Singh TR, Ali AM, Paramasivam M, Pradhan A, Wahengbam K, Seidman M, and Meetei AR, ATR-dependent phosphorylation of FANCM at Serine 1045 is essential for FANCM functions, Cancer Research , 73(14): 4300–4310. , 2013, JIF: 12.7, Click Here (DOI)
  13. Ali AM, Pradhan A, Singh TR, Du C, Li J, Wahengbam K, Grassman E, Auerbach AD, Pang Q, Meetei AR. , FAAP20: a novel ubiquitin-binding FA nuclear core complex protein required for functional integrity of the FA-BRCA DNA repair pathway, Blood, 119(14): 3285–3294, 2012, JIF: 22.1, Click Here (DOI)
  14. Singh TR, Saro D, Ali AM, Zheng X, Du Ch, Killen MW, Sachpatzidis A Wahengbam k, Pierce AJ, XiongY, Sung P, Meetei AR, MHF1-MHF2, a Histone-Fold-Containing Protein Complex, Participates in the Fanconi Anemia Pathway via FANCM, Molecular Cell, 37, 879-886, 2010, JIF: 17.9, Click Here (DOI)
  15. Wang F, Yang Y, Singh TR, Busygina V, Guo R, Wan K, Wang W, Sung P, Meetei AR, Lei M, Crystal Structures of RMI1 and RMI2, Two OB-fold Regulatory Subunits of BML Complex, Structure, 18(9):1159-70, 2010, JIF: 5, Click Here (DOI)
  16. Singh TR, Bakker ST, Agarwal S, Jansen M, Grassman E, Godthelp BC, Ali AM, Du Ch, Rooimans MA, Fan Q, Wahengbam K, Steltenpool J,. Andreassen PR, Williams DA, Joenje H, Winter JP and Meetei AR, Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M, Blood, 114(1):174-80, 2009, JIF: 22.1, Click Here (DOI)
  17. Singh TR, Ali AM, Busygina V, Raynard S, Fan Q, Du Ch, Anderssen PR, Sung P, Meetei AR. , BLAP18/RMI2, a novel OB-fold containing, is essential component of Bloom helicase-double Holliday junction dissolvasome. , Genes & Development, 22: 2856-2868, 2008, JIF: 11.3, Click Here (DOI)
  18. Meetei AR, Medhurst AL, Ling C, Xue Y, Singh TR, Bier P, Steltenpool J, Stone S, Dokal I, Mathew CG, Hoatlin M, Joenje H, de Winter JP, Wang W, A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation Group M, Nature Genetics, 37 (9): 958-63, 2005, JIF: 38.3, Click Here (DOI)
  19. Singh TR, Shankar S, Srivastava RK, HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma. , Oncogene, 24 (29): 4609-23, 2005, JIF: 9.8, Click Here (DOI)
  20. Shankar S, Singh TR, Srivastava RK, Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo, Prostate, 61 (1) 35-49., 2004, JIF: 4.1, Click Here (DOI)
  21. Shankar S, Singh TR, Chen X, Thakkar H, Firnin J, Srivastava RK , The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice.. , Int. J Oncol, 24(5): 1133-40 , 2004, JIF: 5.6, Click Here (DOI)
  22. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. , Synnergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and regression of breast carcinoma in vivo, Cancer Research, 63(17): 5390-400 , 2003, JIF: 12.7, Click Here (DOI)
  23. Singh N, Singh RT, Sundar S. , Novel mechanism of drug resistance in kala azar field isolates., Journal of Infectious Diseases, 188(4):600-7, 2003, JIF: 5.2, Click Here (DOI)